WARS2 and hepatocellular carcinoma: Then, a cell viability assay indicated that depletion of WARS2-AS1 and MKLN1-AS sensitized HCC cell to elesclomol-induced death in a dose-dependent manner, while NRAV deficiency had no effect on elesclomol (Figures 11D–I).